Complications of hysterectomy in women with von Willebrand disease
- PMID: 19473420
- PMCID: PMC3740955
- DOI: 10.1111/j.1365-2516.2009.02022.x
Complications of hysterectomy in women with von Willebrand disease
Abstract
Case reports and small case series suggest that women with von Willebrand disease (VWD) are at a very high risk of bleeding complications with hysterectomy. As the procedure may be beneficial to women who suffer from heavy menstrual bleeding and have completed childbearing, an understanding of the true risks involved is essential for appropriate decision making. To estimate the incidence of bleeding and other complications in women with VWD who undergo hysterectomy. The United States Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality for the years 1988-2004 was queried for all hysterectomies for non-malignant conditions. Data were analysed based on the NIS sampling design. Bivariate analyses were used to examine the differences between women with and without VWD. Multivariate analysis was used to adjust for potential confounders among women who underwent hysterectomy for heavy menstrual bleeding. 545 of the 1 358 133 hysterectomies were to women with VWD. Women with VWD were significantly more likely to experience intraoperative and postoperative bleeding (2.75% vs. 0.89%, P < 0.001) and require transfusion (7.34% vs. 2.13%, P < 0.001) than women without VWD. One woman with VWD died. While the risk of bleeding complications from hysterectomy in women with VWD is smaller than previously reported, women with VWD did experience significantly more bleeding complications than women without VWD. Nonetheless, for women who have completed childbearing, the risks of hysterectomy may be acceptable.
Conflict of interest statement
The authors stated that they had no interests which might be perceived as posing a conflict or bias.
Similar articles
-
Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease.J Thromb Haemost. 2007 Jun;5(6):1165-9. doi: 10.1111/j.1538-7836.2007.02563.x. J Thromb Haemost. 2007. PMID: 17403089
-
Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study.J Womens Health (Larchmt). 2022 Sep;31(9):1262-1270. doi: 10.1089/jwh.2022.0082. Epub 2022 Aug 12. J Womens Health (Larchmt). 2022. PMID: 35960825 Free PMC article.
-
Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease.Haemophilia. 2018 Nov;24(6):950-956. doi: 10.1111/hae.13552. Epub 2018 Jul 10. Haemophilia. 2018. PMID: 29989261
-
Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review.Blood Rev. 2023 Nov;62:101131. doi: 10.1016/j.blre.2023.101131. Epub 2023 Sep 7. Blood Rev. 2023. PMID: 37716881 Review.
-
Von Willebrand disease.Obstet Gynecol Surv. 2006 Feb;61(2):136-45. doi: 10.1097/01.ogx.0000197818.94002.91. Obstet Gynecol Surv. 2006. PMID: 16433937 Review.
Cited by
-
The Cost of Von Willebrand Disease in Europe: The CVESS Study.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221120583. doi: 10.1177/10760296221120583. Clin Appl Thromb Hemost. 2022. PMID: 35979588 Free PMC article.
-
Von Willebrand disease screening in women undergoing hysterectomy for heavy menstrual bleeding.Haemophilia. 2019 May;25(3):e188-e191. doi: 10.1111/hae.13709. Epub 2019 Feb 28. Haemophilia. 2019. PMID: 30817072 Free PMC article. No abstract available.
-
Heavy menstrual bleeding: work-up and management.Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):236-242. doi: 10.1182/asheducation-2016.1.236. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913486 Free PMC article. Review.
-
Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists.Am J Obstet Gynecol. 2012 Oct;207(4):269.e1-5. doi: 10.1016/j.ajog.2012.07.010. Epub 2012 Jul 16. Am J Obstet Gynecol. 2012. PMID: 22901979 Free PMC article.
-
Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.Haemophilia. 2011 Jul;17 Suppl 1(0 1):6-13. doi: 10.1111/j.1365-2516.2011.02558.x. Haemophilia. 2011. PMID: 21692922 Free PMC article.
References
-
- Foster PA. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995;74:784–90. - PubMed
-
- Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol. 1991;98:909–18. - PubMed
-
- Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999;5:313–7. - PubMed
-
- Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol. 2000;111:1236–9. - PubMed
-
- Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6:643–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
